Año: 2013
Journal Impact Factor (JIF): 5.4390
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 6/72 | Q1 | T1 | D1 |
| PHARMACOLOGY & PHARMACY | SCIE | 17/256 | Q1 | T1 | D1 |
| MICROBIOLOGY | SCIE | 17/119 | Q1 | T1 | D2 |
Año: 2017
Journal Citation Indicator (JCI): 1,660
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 8/111 | Q1 | T1 | D1 | 93,24 |
| MICROBIOLOGY | 14/145 | Q1 | T1 | D1 | 90,69 |
| PHARMACOLOGY & PHARMACY | 16/336 | Q1 | T1 | D1 | 95,39 |
Año:
2013
CiteScore:
9,200
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| General Medicine | 278/3233 | Q1 | T1 | D1 |
| Infectious Diseases | 15/237 | Q1 | T1 | D1 |
| Pharmacology | 19/310 | Q1 | T1 | D1 |
| Pharmacology (medical) | 10/225 | Q1 | T1 | D1 |
SJR año:
2013
Factor de Impacto:
2,479
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 17/295 | Q1 | T1 | D1 |
| Pharmacology | 17/354 | Q1 | T1 | D1 |
| Pharmacology (medical) | 9/276 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Basilea | - |
| Medicines Company | - |
| Novartis | - |
| Pfizer | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Quotient Bioresearch Ltd (United States) | |
| 2 | Seifert, H | University of Cologne (Germany) |
| 3 | Canton, R | Hospital Ramon y Cajal (Spain) |
| 4 | Nordmann, P | Hopital de Bicetre (France) |
| 5 | Stefani, S | Università degli Studi di Catania (Italy) |
| 6 | MacGowan, A | Southmead Hospital Bristol (United Kingdom) |
| 7 | Janes, R | Quotient Bioresearch Ltd (United States) |
| 8 | Knight, D | Quotient Bioresearch Ltd; University of Western Australia (United States) |
| # | Autoría grupal | Afiliación |
| 1 | Pascual, A. | Sin datos () |